Cargando…

Biparatopic Protein Nanoparticles for the Precision Therapy of CXCR4(+) Cancers

SIMPLE SUMMARY: Aimed at minimizing side toxicities cancer therapies require appropriate functional vehicles at the nanoscale, for receptor-mediated tumor-targeted drug delivery. The aim of the present study was to explore the human peptide EPI-X4 as a CXCR4-targeting agent in self-assembled, protei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cano-Garrido, Olivia, Álamo, Patricia, Sánchez-García, Laura, Falgàs, Aïda, Sánchez-Chardi, Alejandro, Serna, Naroa, Parladé, Eloi, Unzueta, Ugutz, Roldán, Mònica, Voltà-Durán, Eric, Casanova, Isolda, Villaverde, Antonio, Mangues, Ramón, Vázquez, Esther
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230831/ https://www.ncbi.nlm.nih.gov/pubmed/34208189 http://dx.doi.org/10.3390/cancers13122929

Ejemplares similares

Fluorescent Dye Labeling Changes the Biodistribution of Tumor-Targeted Nanoparticles
por: Álamo, Patricia, et al.
Publicado: (2020)

Time-Prolonged Release of Tumor-Targeted Protein–MMAE Nanoconjugates from Implantable Hybrid Materials
por: Serna, Naroa, et al.
Publicado: (2022)

Selective delivery of T22-PE24-H6 to CXCR4(+) diffuse large B-cell lymphoma cells leads to wide therapeutic index in a disseminated mouse model
por: Falgàs, Aïda, et al.
Publicado: (2020)

Artificial Inclusion Bodies for Clinical Development
por: Sánchez, Julieta M., et al.
Publicado: (2019)

An Auristatin nanoconjugate targeting CXCR4+ leukemic cells blocks acute myeloid leukemia dissemination
por: Pallarès, Victor, et al.
Publicado: (2020)

T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo
por: Núñez, Yáiza, et al.
Publicado: (2023)

The Diphtheria Toxin Translocation Domain Impairs Receptor Selectivity in Cancer Cell-Targeted Protein Nanoparticles
por: Voltà-Durán, Eric, et al.
Publicado: (2022)

Specific Cytotoxic Effect of an Auristatin Nanoconjugate Towards CXCR4(+) Diffuse Large B-Cell Lymphoma Cells
por: Falgàs, Aïda, et al.
Publicado: (2021)

Ion-dependent slow protein release from in vivo disintegrating micro-granules
por: Álamo, Patricia, et al.
Publicado: (2021)

An In Silico Methodology That Facilitates Decision Making in the Engineering of Nanoscale Protein Materials
por: Parladé, Eloi, et al.
Publicado: (2022)

Self-Assembled Nanobodies as Selectively Targeted, Nanostructured, and Multivalent Materials
por: Sánchez-García, Laura, et al.
Publicado: (2021)

GSDMD-dependent pyroptotic induction by a multivalent CXCR4-targeted nanotoxin blocks colorectal cancer metastases
por: Sala, Rita, et al.
Publicado: (2022)

CXCR4-targeted nanotoxins induce GSDME-dependent pyroptosis in head and neck squamous cell carcinoma
por: Rioja-Blanco, Elisa, et al.
Publicado: (2022)

Self-assembling protein nanocarrier for selective delivery of cytotoxic polypeptides to CXCR4(+) head and neck squamous cell carcinoma tumors
por: Rioja-Blanco, Elisa, et al.
Publicado: (2022)

A Novel CXCR4-Targeted Diphtheria Toxin Nanoparticle Inhibits Invasion and Metastatic Dissemination in a Head and Neck Squamous Cell Carcinoma Mouse Model
por: Rioja-Blanco, Elisa, et al.
Publicado: (2022)

A CXCR4-targeted nanocarrier achieves highly selective tumor uptake in diffuse large B-cell lymphoma mouse models
por: Falgàs, Aïda, et al.
Publicado: (2020)

Potent Anticancer Activity of CXCR4-Targeted Nanostructured Toxins in Aggressive Endometrial Cancer Models
por: Medina-Gutiérrez, Esperanza, et al.
Publicado: (2022)

Biofabrication of functional protein nanoparticles through simple His-tag engineering
por: López-Laguna, Hèctor, et al.
Publicado: (2021)

Selective depletion of metastatic stem cells as therapy for human colorectal cancer
por: Céspedes, María Virtudes, et al.
Publicado: (2018)

Intracellular CXCR4(+) cell targeting with T22-empowered protein-only nanoparticles
por: Unzueta, Ugutz, et al.
Publicado: (2012)

Antibacterial Activity of T22, a Specific Peptidic Ligand of the Tumoral Marker CXCR4
por: Serna, Naroa, et al.
Publicado: (2021)

The Poly-Histidine Tag H6 Mediates Structural and Functional Properties of Disintegrating, Protein-Releasing Inclusion Bodies
por: Sánchez, Julieta María, et al.
Publicado: (2022)

Efficient bioactive oligonucleotide‐protein conjugation for cell‐targeted cancer therapy
por: Aviñó, Anna, et al.
Publicado: (2019)

Efficient Delivery of Antimicrobial Peptides in an Innovative, Slow-Release Pharmacological Formulation
por: Serna, Naroa, et al.
Publicado: (2023)

Novel Endometrial Cancer Models Using Sensitive Metastasis Tracing for CXCR4-Targeted Therapy in Advanced Disease
por: Medina-Gutiérrez, Esperanza, et al.
Publicado: (2022)

CXCR7 expression in diffuse large B-cell lymphoma identifies a subgroup of CXCR4+ patients with good prognosis
por: Moreno, María José, et al.
Publicado: (2018)

Bacterial mimetics of endocrine secretory granules as immobilized in vivo depots for functional protein drugs
por: Céspedes, María Virtudes, et al.
Publicado: (2016)

Structural and functional features of self-assembling protein nanoparticles produced in endotoxin-free Escherichia coli
por: Rueda, Fabián, et al.
Publicado: (2016)

Functional inclusion bodies produced in the yeast Pichia pastoris
por: Rueda, Fabián, et al.
Publicado: (2016)

Toxicity Profiling of Bacterial Inclusion Bodies in Human Caco-2 Cells
por: Barguilla, Irene, et al.
Publicado: (2022)

Probing the Biosafety of Implantable Artificial Secretory Granules for the Sustained Release of Bioactive Proteins
por: Álamo, Patricia, et al.
Publicado: (2023)

Subcutaneous preconditioning increases invasion and metastatic dissemination in mouse colorectal cancer models
por: Alamo, Patricia, et al.
Publicado: (2014)

In Vivo Bactericidal Efficacy of GWH1 Antimicrobial Peptide Displayed on Protein Nanoparticles, a Potential Alternative to Antibiotics
por: Carratalá, Jose V., et al.
Publicado: (2020)

Enhancement of Polymeric Immunoglobulin Receptor Transcytosis by Biparatopic VHH
por: Emmerson, Chris D., et al.
Publicado: (2011)

Editorial: High added-value nanoparticles: Rethinking and recycling cell protein waste
por: Unzueta, Ugutz, et al.
Publicado: (2022)

Structural insights into the mechanism of action of a biparatopic anti-HER2 antibody
por: Oganesyan, Vaheh, et al.
Publicado: (2018)

Engineering an anti-HER2 biparatopic antibody with a multimodal mechanism of action
por: Kast, Florian, et al.
Publicado: (2021)

Focal Adhesion Genes Refine the Intermediate-Risk Cytogenetic Classification of Acute Myeloid Leukemia
por: Pallarès, Victor, et al.
Publicado: (2018)

A biparatopic agonistic antibody that mimics fibroblast growth factor 21 ligand activity
por: Shi, Sally Yu, et al.
Publicado: (2018)

uPA/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy
por: Pavón, Miguel Angel, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_28vhrj3bo0tk2g2gjulu2aa0dp